PDA

View Full Version : Press Releases

  1. FDA Approves Nplate™ For Long-Term Treatment Of Adult Chronic ITP
  2. New free-standing clinic in Arkansas
  3. Nano Tech Hemostat!
  4. Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clin
  5. Blood clotting protein linked to rheumatoid arthritis
  6. Z-Medica now has retail products
  7. Hemo Concepts to Launch Integrated Blood Conservation Program At Texas Heart Institut
  8. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin...
  9. FDA Approves Sealant to Control Bleeding During Surgery
  10. Blood Transfusions May Be Harmful To Some Patients
  11. FDA Approves Voluven to Treat Serious Blood Volume Loss following Surgery
  12. Creighton University Medical Center Accredited by ABC.
  13. BBC article
  14. Bayer Stops Worldwide Sales of Trasylol Pending Safety Data
  15. FDA Approves Mircera: First Renal Anemia Treatment in the US with Monthly Maint...
  16. Bayer Yanks Aprotinin off the Market Pending Analysis of BART
  17. Synthetic Blood International's Oxycyte Featured on PBS' WIRED Science
  18. FDA Sides With CMS in EPO Battle; Labeling Change Next
  19. Medical Study Proves Claims of Natural Extract to Increase Circulating Stem Cells
  20. Stored blood lacks nitric oxide-Yahoo news
  21. Bloodless Cardiac Surgery in Jehovah's Witnesses: Outcomes Compared
  22. Biochip that guarantees safety in blood transfusions
  23. Alliance Pharmaceutical Corp. Completes the Manufacture of Oxygent (TM) for Clinical
  24. Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
  25. A Recombinant EPO and Albumin Fusion
  26. Pre-operative Assessment - Jehovah’s Witnesses (UK Dept of Health)
  27. Anemic Children with Cancer Benefit from Erythropoietin
  28. Blood Avoidance Program Gives Families Options; DeVos Children's Hospital
  29. St. Vincent Healthcare Blood Conservation Program in the news!
  30. ALLIANCE PHARMA - April 20th/2006
  31. Akzo Nobel's Ferrazone iron compound receives FDA acceptance
  32. Alliance Pharmaceutical Corp. Reaches Agreement With Lender Committee.
  33. Hemo Concepts Contracts with Nebraska Methodist Hospital on Blood Conservation
  34. Hemosol has Filed a Notice of Intention to Make a Proposal to its Creditors
  35. Blood Conservation Strategies - Emory University Hospital Forum
  36. PolyHeme Trial to Begin Monday at Duke University Hospital
  37. Substituting blood transfusions
  38. Developing a 'Super'-EPO
  39. FDA Clears Novare's EndoLink(TM) Articulating Instruments for Marketing; Six Degrees
  40. Nuvelo Begins Phase 3 Trial of Alfimeprase for Acute Peripheral Arterial Occlusion, o
  41. MedicalCV Announces Completion of a Series of U.S. Clinical Cases Using the ATRILAZE(
  42. Bayer Initiates Phase III Clinical Study of Trasylol(R) Therapy During Primary Total
  43. Northfield Laboratories Inc. Announces Result of Third Interim Analysis of PolyHeme P
  44. REVLIMID(R) New Drug Application Submitted to FDA for Review
  45. ATS Medical to Participate in the American Association for Thoracic Surgery Meeting
  46. New Research Shows Three Innovative Nonsurgical Bone Tumor Treatments Provide Pain Re
  47. Nonsurgical Cryotherapy for Prostate Cancer, the 'Male Lumpectomy,' Preserves
  48. Biopure Completes Patient Enrollment in European Phase 2 Clinical Trial of Hemopure(R
  49. ThermoGenesis Corp. to Supply Autologous Thrombin Kits to Biomet, Inc.
  50. Alliance Pharmaceutical Corp. and Beijing Double-Crane Pharmaceutical Co., Ltd. Annou
  51. Gish Cardiopulmonary Bypass Equipment Used in Pioneering Transfusion-free Surgery
  52. Transfusion-Free Surgery
  53. Physician response to conflicts between faith and medicine
  54. Heart attack patients who receive blood transfusions have higher death rate
  55. Vitamin B12 Taken Nasally Can Help Patients Starve off Anemia After Gastric Bypass
  56. Blood alternative reduces risk of disease
  57. New Innovative Non-Surgical Cardiac Procedure Provided at Trinitas: Elizabeth, NJ
  58. Haemonetics to Market First Non-Invasive Test for Blood Hematocrit
  59. ProMetic Announces that PRDT's Ligand Technology Binds and Removes Viruses from Blood
  60. Alternative blood salvage device to cell savers
  61. Ready System® 200 as an Alternative to the Traditional Heart Lung Machine and CABG
  62. Aggrastat(R), Added to Heparin, Reduced Complications From Unstable Angina
  63. No Need For Transfusions With New Blood Washer
  64. Biopure Receives FDA Response to Hemopure(R) Marketing Application
  65. U.S. FDA Finalizes Response Date for Biopure's Marketing Application of Hemopure
  66. Sangart Initiates Phase Ib/ii Clinical Trial For Hemospan(tm)
  67. Tissuelink Medical
  68. Tissuelink Medical Receives Fda Clearance For The Hemostatic Sealing And ...